hit counter

Low Dose LSD for Depression Treatment: Preliminary Efficacy (2023 Study)

Recent research exploring the use of low doses of LSD (Lysergic acid diethylamide) in treating depression marks a significant shift in the psychiatric landscape. This innovative approach seeks to understand and harness the potential therapeutic benefits of psychedelics, which were once stigmatized and largely overlooked in clinical settings. Highlights: Study Design: The research employed a …

Read more

Vortioxetine Efficacy for Major Depression & Comorbid Anxiety (2023 Study)

The RELIEVE study provides pivotal insights into the effectiveness of vortioxetine in treating patients with Major Depressive Disorder (MDD) co-morbid with Generalized Anxiety Disorder (GAD). A subgroup analysis of the observational study highlights significant improvements in patient functioning, depression severity, cognitive symptoms, and quality of life. The findings underscore vortioxetine’s potential as a beneficial treatment …

Read more

Polyphenols & Depression: Antidepressant Potential of Plant Compounds

Depression, a prevalent and debilitating mental health condition, affects millions worldwide. Recent studies have shown an intriguing link between dietary polyphenols, naturally occurring compounds in plant-based foods, and depression outcomes. Highlights: Prevalence of Depression: More than 300 million people globally suffer from depression, marking it as a leading cause of disability. Role of Polyphenols: Polyphenols, …

Read more

Best Antidepressants for Preventing Depression Relapse & Maintenance Treatment (Study)

Depression is a complex, often long-term condition requiring careful management. Recent research has shed light on the effectiveness of various antidepressants during the maintenance phase of major depressive disorder (MDD). Highlights: Extensive Study: The meta-analysis included 34 double-blind, placebo-controlled trials with a total of 9,384 participants. Multiple Drugs Analyzed: 20 different antidepressants were compared for …

Read more

Long-Term Antidepressant (SSRI) Use Increasing: Overprescription & Withdrawal Hesitancy

The rise in antidepressant prescribing, especially selective serotonin reuptake inhibitors (SSRIs) since the 1980s, is a complex phenomenon with broad implications for public health. While these medications are crucial for many, the increase in long-term use has raised concerns about overprescription, side effects, and withdrawal challenges. Key Facts: Rising Prescriptions: Antidepressant prescriptions, particularly SSRIs, have …

Read more

Exercise to Treat Depression: Aerobic & Resistance Training Effective Antidepressants?

Exercise has emerged as an effective treatment for depression, rivaling medication and psychotherapy in its ability to reduce symptoms. Both aerobic and resistance training provide mental health benefits, with a combination of the two being optimal. However, exercise is vastly underutilized and more research is needed to uncover the mechanisms behind its antidepressant effects. Highlights: …

Read more

Allopregnanolone Agonists for Depression: Brexanolone & Zuranolone in Focus (2023)

Allopregnanolone agonists represent a promising new class of medications for treating depressive disorders. Evidence suggests that allopregnanolone agonists exhibit rapid-onset of antidepressant action – particularly in women with postpartum depression (PPD). Key facts: Allopregnanolone is a neurosteroid that acts as a positive allosteric modulator of GABAA receptors and is decreased in depressive disorders. The allopregnanolone …

Read more